The rise of Advanced Therapy Medicinal Products (ATMPs), such as CAR-T cell therapies and gene vectors, has created a need for highly specialized analytical testing that traditional labs cannot provide. These therapies require complex assays for Vector Copy Number (VCN), Infectious Titer, and Cell Viability. Unlike small-molecule drugs, these products are living biological entities, meaning the...